BioMarin Pharmaceutical
BMRN
#1831
Rank
$11.00 B
Marketcap
$57.24
Share price
1.33%
Change (1 day)
-19.03%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): $0.48 Billion USD

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are $3.22 Billion USD. a decrease over its 2024 earnings that were of $0.54 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 $0.48 B-10.94%
2024 $0.54 B187.31%
2023 $0.18 B26.07%
2022 $0.14 B-298.51%
2021 -$75.35 Million78.04%
2020 -$42.33 Million-55.36%
2019 -$94.82 Million-33.56%
2018 -$0.15 Billion297.78%
2017 -$35.88 Million-95.68%
2016 -$0.84 Billion437.12%
2015 -$0.16 Billion23.91%
2014 -$0.13 Billion-29.25%
2013 -$0.18 Billion49.23%
2012 -$0.12 Billion171.11%
2011 -$43.63 Million103.01%
2010 -$21.49 Million-3903.54%
2009 $0.56 M-98.31%
2008 $33.42 M-189.7%
2007 -$37.27 Million51.02%
2006 -$24.68 Million-61.58%
2005 -$64.22 Million-56.59%
2004 -$0.15 Billion95.13%
2003 -$75.81 Million12.09%
2002 -$67.63 Million73.19%
2001 -$39.05 Million18.32%
2000 -$33.01 Million19.65%
1999 -$27.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
$7.69 B 1,495.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-$0.51 Billion-205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.11 Billion-122.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$27.45 Million-105.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$0.19 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
$0.28 B-41.24%๐Ÿ‡บ๐Ÿ‡ธ USA